Literature DB >> 10447224

High prevalence of hypophosphataemia amongst patients with infectious diseases. A retrospective study.

L Håglin1, L A Burman, M Nilsson.   

Abstract

OBJECTIVES: To describe the prevalence of hypophosphataemia amongst all patients treated during 1993 for infectious diseases. The associations between serum C-reactive protein, serum albumin and white blood cells in blood were studied amongst hypophosphataemic patients. Comparisons were made according to the severity of infection.
DESIGN: A retrospective study of the prevalence of hypophosphataemia, and a case-control study amongst a subgroup of patients.
SETTING: The Department of Infectious Diseases, University Hospital, Umeå, Sweden.
SUBJECTS: For the prevalence study all 967 patients (449 women and 518 men) treated during 1993 were included. In the case-control study, 108 cases, with serum phosphate < or =0.64 mmol L(-1), 216 age-and sex-matched controls with serum phosphate >0.82 mmol L(-1) (men) and >0.86 mmol L(-1) (women), respectively, were included.
RESULTS: In 402 of 967 patients (42%) at least one serum phosphate value was below the reference level. Hypophosphataemia was found in 573 of 1966 blood samples (29%). Severe hypophosphataemia (<0.30 mmol L(-1)) was seen in 1.2% of the patients (0.9% of blood samples). The prevalence of hypophosphataemia was higher amongst women than amongst men. In the case-control study, the serum C-reactive protein and the number of white blood cells was higher amongst the cases compared with the controls (124 vs. 94 mg L(-1) and 11.4 vs. 9.3 cells/L x10(9), respectively). The multiple logistic regression showed a 4-fold higher risk of having low serum phosphate in patients with severe infection, compared with mild infections. None of the other variables (albumin, days of hospital stay or white blood cells in blood) increased the risk for hypophosphataemia.
CONCLUSIONS: The high prevalence of low serum phosphate levels and the increased risk of having low levels in severe infections shown in this study needs further attention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447224     DOI: 10.1046/j.1365-2796.1999.00540.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

Review 1.  Hypophosphataemia in anorexia nervosa.

Authors:  L Håglin
Journal:  Postgrad Med J       Date:  2001-05       Impact factor: 2.401

2.  Hypophosphatemia in meningococcal sepsis.

Authors:  Charalampos Antachopoulos; Ioannis Papassotiriou
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

3.  Factors contributing to the development of hypophosphataemia when refeeding using parenteral nutrition.

Authors:  Vanessa A Marvin; David Brown; Jane Portlock; Callum Livingstone
Journal:  Pharm World Sci       Date:  2008-03-30

Review 4.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: its relevance to the pathogenesis of diabetic retinopathy.

Authors:  H Vorum; J Ditzel
Journal:  J Ophthalmol       Date:  2014-03-20       Impact factor: 1.909

5.  Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury.

Authors:  Yi Yang; Ping Zhang; Yu Cui; Xia Lang; Jing Yuan; Hua Jiang; Wen Lei; Rong Lv; Yi Zhu; En Lai; Jiang Chen
Journal:  Crit Care       Date:  2013-09-19       Impact factor: 9.097

6.  Clinical and laboratory features associated with serum phosphate concentrations in malaria and other febrile illnesses.

Authors:  Ho-Ming E Suen; Geoffrey Pasvol; Aubrey J Cunnington
Journal:  Malar J       Date:  2020-02-21       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.